Skip to main content
Fig. 3 | Surgical and Experimental Pathology

Fig. 3

From: Prognostic values and clinical implications of programmed cell death-ligand 1 (PD-L1), fork head transcription factor P-1 (FOXP-1) and signal transducer and activator of transcription-3 (STAT-3) expression in diffuse large B-cell lymphoma (DLBCL); an immunohistochemical study

Fig. 3

Immunohistochemical expression of Signal transducer and activator of transcription-3 (STAT-3); (a) High nuclear STAT-3 expression in DLBCL stage IV × 400 (b) High nuclear STAT-3 expression in DLBCL stage III × 400 (c) negative nuclear STAT-3 expression in DLBCL stage I × 400 (d) positive nuclear STAT-3 expression in sections from invasive duct carcinoma of the breast as appositive control of the marker × 400 (e) Negative control by replacement of the primary anti- STAT-3 antibody by phosphate buffered saline × 400

Back to article page

Surgical and Experimental Pathology

ISSN: 2520-8454

Contact us